HRTX

HRTX

USD

Heron Therapeutics Inc. Common Stock

$1.105-0.065 (-5.556%)

即時價格

Healthcare
生物科技
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.170

最高

$1.190

最低

$1.070

交易量

1.54M

公司基本面

市值

202.6M

行業

生物科技

國家

United States

交易統計

平均交易量

1.92M

交易所

NCM

貨幣

USD

52週範圍

最低 $1.04當前 $1.105最高 $2.68

相關新聞

GlobeNewswire

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 millionZYNRELEF® Net

查看更多
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
GlobeNewswire

Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board

查看更多
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
GlobeNewswire

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

CARY, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call

查看更多
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025